College of Bench Scientists Annual Dinner
Tuesday, October 15, 2019, 6PM at Presidio Golf Course
Hosted by David Erle, the College of Bench Scientists Annual dinner is an opportunity for members of the lab-based science community, from trainees to senior faculty, to connect. If you are in this community, you should have received an email invitation from Paperless Post this morning (check your spam folder). If you did not receive one, or notice anyone who was inadvertently missed, please contact Alyssa Tecklenburg.
|
|
 Art Weiss, MD, PhD, Professor of Medicine, Rheumatology, received the 2019 William B. Coley Award for Distinguished Research in Basic Immunology from the Cancer Research Institute.The award is given to one or more scientists for seminal discoveries in the field of basic immunology and cancer immunology.
|
|
 Michael Podolsky, MD, Assistant Professor, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine received a K08 for his project, "Role of Endo180 Regulation in Tissue Fibrosis."
|
|
 Yiwey Shieh, MD, Assistant Professor, Helen Diller Family Comprehensive Cancer Center, received a K08 for his project, "Prediction of Interval Breast Cancer Risk Using Genetic Variants." |
|
 Melissa Conrad, PhD, Assistant Professor, Division of HIV, Infectious Diseases, and Global Medicine, received a K01 for her project, "Impact of Antimalarials and Insecticide Resistance on Malaria Transmission in Uganda."
|
|
 Krista Harrison, PhD, Assistant Professor, Division of Geriatrics, received a K01 for her project, "Palliative Care for People Living at Home with Advancing Dementia and Their Caregivers." |
|
 Paul Krezanoski, MD, Assistant Professor, Division of Hospital Medicine, received a K23 for his project, "Objective Monitoring of Bednet Adherence to Improve Malaria Prevention." |
|
 Lillian Brown, MD, PhD, Assistant Professor, Division of HIV, Infectious Diseases, and Global Medicine, received a K23 for her project, "Leveraging Social Networks to Improve Retention in Care and Viral Suppression Among HIV-Infected Youth in East Africa."
|
|
 Meredith Greene, MD, Assistant Professor of Medicine, Division of Geriatrics, received a K76 for her project, "Tailored Geriatric Assessment and Management for HIV Care Settings."
|
|
K Info Session for Basic Science Physician-Scientists
|
|
|
 Are you an MD or MD/PhD bench scientist thinking about submitting/re-submitting a K? Or are you already supported by a K? An informal session will be held in early October with other pre-independent basic science physician-scientists at various stages of the K (pre-, writing-, on-K) to share advice, resources, and support. Please contact Rachel Rutishauser by September 20th, if you would like to attend. Date/Time/Location TBD (based on preferences of those interested); Zoom will be available.
|
|
NIH Loan Repayment Program
|
|
|
 Application Cycle Opened on Sunday, September 1st
Awardees can receive up to $100,000 of qualified educational debt repayment with a two-year contract. The LRP application cycle closes on November 15th. To learn more go to www.lrp.nih.gov, or click the button below to apply!
|
|
DOM Team Science Planning Grant 
Application deadline is November 1st
The Team Science Planning Grant will offer grants of up to $100,000 for a period of 12 months to spur the development of new multi-disciplinary grant submissions.
The deadline for this grant is November 1, 2019 with funding beginning January 1, 2020. To review eligibility and criteria and program details and to apply, please click on the button below.
|
|
UCSF RAP Community Partnership Supplement
RAP submission deadline is September 23rd at 2pm (PST)
Clinical investigators, please note: there is an additional community partnership supplement available for this cycle of RAP. We know many of you have or desire to do community-based research, and this opportunity could help jump start your efforts.
The UCSF School of Medicine's (SOM) Strategic Plan Action Group on Community Partnerships is supporting a pilot of a RAP Community Partnership Supplement, where a SOM PI1 or PI2 can propose a community engagement component to their RAP research proposal. Two eligible awarded RAP applications will be selected to receive an additional $15,000 (at least half the funding needs to be dedicated to the community partner), based on evaluation of a community engagement component by the Community Partnerships Team. This component can be optionally added as a section in the proposal portion of your RAP application.
Some of the support the Community Partnership Team can provide you includes: finding a community collaborator with similar interests, establishing a relationship with a community partner, managing the steps of setting up a research project with a partner, determining the best research methods and methods training design for your study, designing an outreach or dissemination plan for your research process and findings, framing your community-engaged funding proposal so it is competitive and exploring the degree of involvement that would work best for you.
Please be sure to contact the Community Partnership Team as soon as possible if you need technical assistance. For clarification, questions and consultations, please contact either Wylie.Liu@ucsf.edu or Tracey.Woodruff@ucsf.edu.
|
|
 DOM PREPARE Program
Applications will be reviewed on a rolling basis
The DOM has launched the "PRE-Proposal Application REview (PREPARE)” program. The primary mission of PREPARE is to provide pre-submission grant review services with the goal of improving the funding rate for DOM PIs. Both reviewers and reviewees can now apply for submission deadlines that occur after November 1, 2019. More details and sign up forms can be found by clicking the button below.
|
|
UCSF Applications for Chan Zuckerberg Physician-Scientist Fellowship Program 
Application deadline is October 1st
Chan Zuckerberg Biohub is launching a new Physician-Scientist Fellowship Program. Physician-scientists will be trained in a multidisciplinary approach that allows them to link the biomedical sciences to the clinical care of patients. The Fellowship Program will be led by Ethan Weiss, MD, of CVRI and Cardiology, and will give clinicians the opportunity to work closely with scientists and train in disciplines that promise to transform current paradigms of patient care. This 22-to-36 month program will begin on July 1st, 2020. Fellows or faculty who are interested in applying, please email Ethan Weiss at Ethan.Weiss@ucsf.edu or access the application by clicking on the button below. Most importantly, no prior research experience is required!
|
|
Industry Partnership Opportunity
|
|
|
Non-UCSF Novo Nordisk - A Global Healthcare Company Focused on Diabetes Care
Application deadline is September 16th
Novo Nordisk is working with UCSF Innovation Ventures to find UCSF investigators who can participate in their San Francisco Partnering Day in 2020 and collaborate with Novo Nordisk in the future. Senior leaders from Novo Nordisk will be in San Francisco to meet with local biotech companies, start-ups, and scientists at academic institutions throughout the day.
Novo Nordisk Partnering Day will have three tracks:
1) Stem cell technology
2) Cardiometabolic diseases: Diabetes, obesity, NASH, cardiovascular disease/atherosclerosis
3) Technology: Machine learning/AI (drug discovery), protein technology platforms, microbiome, and other innovative platform technologies
If you are interested in participating, click the button below to apply. For questions, contact Yuxi Lin.
|
|
Why You Should Review Grants for NIH Study Section– For Free
|
|
|
 Edwin Charlebois, MPH, PhD, is an infectious diseases epidemiologist and Professor of Medicine in the Division of Prevention Science, and serves as the Co-Director of the Methods Core at the UCSF Center for AIDS Prevention Studies. He is currently reviewing for NIH’s Dissemination and Implementation Research in Health Study Section – DIRH.
"I have found that there are two compelling reasons to review grants for NIH Study Section: scientific altruism and enlightened self-interest. The opportunity to help shape the direction and quality of future research is significant and the formation of multiple career-enhancing networking connections, increasing your visibility and recognition on the national and international stage, and exposure to other disciplines and approaches all can aide you in becoming a better scientist and mentor as well as advance your research and academic career. Additionally, you get to meet some really stellar individuals and the occasional colorful character that some of you may suspect was akin to a memorable reviewer of one of your own past grants…"
|
|
Update on Approval Times for Minimum Risk IRB Studies
|
|
|
Unfortunately, IRB times for Minimal Risk studies have lengthened again due to staffing shortages. The median time to wait for an assignment to an IRB analyst is several months. We share some key information from the IRB bulletin of investigator survival until staffing is restored.
Q. What can the study team do to speed things up?
One of the most frequent reasons the IRB sends stipulations is that the submission materials are incomplete or inconsistent. Here are our tips for a smoother review experience:
- Before submitting your study, have a colleague proofread ALL of your submission materials and give feedback on anything that seems missing, confusing, or inconsistent. If you are a student, resident, or post-doc, your faculty mentor/advisor should do this review for study design and completeness. Having your study carefully proofread and corrected could improve approval time by weeks.
- Respond to stipulations promptly. On average, the time that study teams take to respond to stipulations accounts for nearly one-half of the total time to approval.
- Consider the option to seek IRB approval from a commercial IRB, if your funding would support this. Read about the criteria and guidance here.
Q. What are criteria for a "rush request," and how do I request one?
Generally, new minimal risk submissions are reviewed in the order that they were submitted. However, sometimes there are conditions which necessitate that a study skips the line, and we refer to these as “rush” requests. The most common examples of circumstances in which the IRB would honor a rush request are:
- NIH “Just in Time” (JIT) studies, where the PI is informed of a short turnaround time to provide IRB approval in order to receive an award
- Disease outbreak or a disease “season”
- Students/Residents/Fellows on a timeline for educational reasons
In iRIS, once you have completed the application you will be brought to a form called the Initial Review Submission Packet. This form has a section titled “Special Processing Instructions or Information about the Submission” where you should explain your timeline and state when approval is needed.
If you are informed of a timeline issue after the study has been submitted, please send an email to the main IRB inbox and the message will be forwarded to the Expedited/Exempt Manager for prioritization.
New minimal risk studies are triaged daily by the IRB administrative staff, and each rush request is sent to the Expedited/Exempt Manager for consideration and prioritizes distribution to analysts based on the PI’s proposed deadlines.
|
|
|
|
